<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>医药魔方Pro | wechat-feeds</title><link>http://MzU1MTk1NTUwMA.favicon.privacyhide.com/favicon.ico</link><description>聚焦生物医药前沿，洞察研发投资风向</description><managingEditor> (hellodword)</managingEditor><pubDate>Thu, 01 Apr 2021 21:29:22 +0800</pubDate><image><url>http://MzU1MTk1NTUwMA.favicon.privacyhide.com/favicon.ico</url><title>医药魔方Pro | wechat-feeds</title><link>http://MzU1MTk1NTUwMA.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>Science：人类癌症与微生物组「图鉴」</title><link>https://mp.weixin.qq.com/s/zY6j5gHlDnHsZQF7arz3UQ</link><description></description><content:encoded><![CDATA[Science：人类癌症与微生物组「图鉴」]]></content:encoded><pubDate>Thu, 01 Apr 2021 20:59:20 +0800</pubDate></item><item><title>开发表观遗传调控疗法！Omega 完成1.26亿美元C轮融资，首个产品瞄准肝癌</title><link>https://mp.weixin.qq.com/s/hvnuItEzJuM_3MrRKwFf9Q</link><description></description><content:encoded><![CDATA[开发表观遗传调控疗法！Omega 完成1.26亿美元C轮融资，首个产品瞄准肝癌]]></content:encoded><pubDate>Wed, 31 Mar 2021 21:00:15 +0800</pubDate></item><item><title>杨大俊点评 | 颠覆认知：p53“铁搭档”MDM2，竟是抗癌帮手</title><link>https://mp.weixin.qq.com/s/rKGa0-UhtC_cXhbZXj8y3Q</link><description></description><content:encoded><![CDATA[杨大俊点评 | 颠覆认知：p53“铁搭档”MDM2，竟是抗癌帮手]]></content:encoded><pubDate>Tue, 30 Mar 2021 21:00:59 +0800</pubDate></item><item><title>三阴性乳腺癌治疗新靶点——FGD5 | 中国科学家Science子刊最新成果</title><link>https://mp.weixin.qq.com/s/jvYTHRCEqPaz7k94hHwlUQ</link><description></description><content:encoded><![CDATA[三阴性乳腺癌治疗新靶点——FGD5 | 中国科学家Science子刊最新成果]]></content:encoded><pubDate>Mon, 29 Mar 2021 21:21:54 +0800</pubDate></item><item><title>PROTAC新应用：成功降解CDK2 | Nature子刊最新成果</title><link>https://mp.weixin.qq.com/s/yqYqnT4dvDUltnnx4Q3neQ</link><description></description><content:encoded><![CDATA[PROTAC新应用：成功降解CDK2 | Nature子刊最新成果]]></content:encoded><pubDate>Sun, 28 Mar 2021 20:57:56 +0800</pubDate></item><item><title>PD-1抗体“超强搭档”：联合长效IL-2融合蛋白，小鼠肿瘤完全缓解</title><link>https://mp.weixin.qq.com/s/_6vtYHY9fV0SMVCb88yvMw</link><description></description><content:encoded><![CDATA[PD-1抗体“超强搭档”：联合长效IL-2融合蛋白，小鼠肿瘤完全缓解]]></content:encoded><pubDate>Sat, 27 Mar 2021 21:00:48 +0800</pubDate></item><item><title>颠覆抗癌治疗后，免疫疗法能否挽救帕金森病？</title><link>https://mp.weixin.qq.com/s/b90yPv9J2TCsIz-uRTnZ1w</link><description></description><content:encoded><![CDATA[颠覆抗癌治疗后，免疫疗法能否挽救帕金森病？]]></content:encoded><pubDate>Fri, 26 Mar 2021 20:58:23 +0800</pubDate></item><item><title>Nature：癌症免疫治疗新靶点——细菌肽</title><link>https://mp.weixin.qq.com/s/azXLWCEqu96UQDbPDNYgtw</link><description></description><content:encoded><![CDATA[Nature：癌症免疫治疗新靶点——细菌肽]]></content:encoded><pubDate>Thu, 25 Mar 2021 20:58:31 +0800</pubDate></item><item><title>新型偶联药物VDC来了！Aura完成8000万美元新一轮融资，核心产品迈向III期临床</title><link>https://mp.weixin.qq.com/s/h_tVMrllR10r9dW6Ut8D3A</link><description></description><content:encoded><![CDATA[新型偶联药物VDC来了！Aura完成8000万美元新一轮融资，核心产品迈向III期临床]]></content:encoded><pubDate>Wed, 24 Mar 2021 21:01:02 +0800</pubDate></item><item><title>两篇Nature抗癌新突破：表观遗传新靶点——NSD3</title><link>https://mp.weixin.qq.com/s/Css24E4jRqT3B8OJ5lZ__A</link><description></description><content:encoded><![CDATA[两篇Nature抗癌新突破：表观遗传新靶点——NSD3]]></content:encoded><pubDate>Tue, 23 Mar 2021 21:05:19 +0800</pubDate></item></channel></rss>